Kidney Cancer
468
61
84
264
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
92 trials with published results (20%)
Research Maturity
264 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.5%
49 terminated out of 468 trials
84.3%
-2.2% vs benchmark
9%
40 trials in Phase 3/4
35%
92 of 264 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 264 completed trials
Clinical Trials (468)
Distance-Based Exercise to Preserve Function and Prevent Disability
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
NSAID Use After Robotic Partial Nephrectomy
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders